{{author}}{{author}}{{($index > metadata.AuthorsAndEtalArray.length-1) ? ',' : '.'}}

Michelle Cornes, Robert W Aldridge, Elizabeth Biswell, Richard Byng, Michael Clark, Graham Foster, James Fuller, Andrew Hayward, Nigel Hewett, Alan Kilmister, Jill Manthorpe, Joanne Neale, Michela Tinelli & Martin Whiteford.

Michelle Cornes ^1,*, Robert W Aldridge ², Elizabeth Biswell ¹, Richard Byng ³, Michael Clark ⁴, Graham Foster ⁵, James Fuller ¹, Andrew Hayward ², Nigel Hewett ⁶, Alan Kilmister ¹, Jill Manthorpe ¹, Joanne Neale ⁷, Michela Tinelli ⁴, Martin Whiteford ⁸

¹ Health and Social Care Workforce Research Unit, King’s College London, London, UK
² Institute of Health Informatics, University College London, London, UK
³ Clinical Trials and Health Research, University of Plymouth, Plymouth, UK
⁴ Care Policy and Evaluation Centre, London School of Economics and Political Science, London, UK
⁵ Blizard Institute, Queen Mary University of London, London, UK
⁶ Pathway and the Faculty for Homeless and Inclusion Health, London, UK
⁷ National Addiction Centre, Institute of Psychiatry, Psychology & Neuroscience, King’s College London, London, UK
⁸ Department of Community Nursing and Community Health, Glasgow Caledonian University, Glasgow, UK
^* Corresponding author Email: michelle.cornes@kcl.ac.uk

In memory of Darren O’Shea (1977–2021).

In memory of Darren O’Shea (1977–2021).

Declared competing interests of authors: Michael Clark was a member of the COVID-19 reviewing committee (2020–1) and Prophylaxis Platform Study Funding Committee (25 November 2020). Graham Foster reports consultancy and speaker fees from Gilead Sciences (Foster City, CA, USA), F. Hoffman-La Roche Ltd (Basel, Switzerland), uniQure (Amsterdam, the Netherlands) and BioMarin Pharmaceutical (Novato, CA, USA). Andrew Hayward reports membership of the National Institute for Health Research Health Technology Assessment Antimicrobial Resistance Themed Call Board (2013–14).